Cibc World Markets Corp Alkermes Plc. Transaction History
Cibc World Markets Corp
- $16.6 Billion
- Q4 2024
A detailed history of Cibc World Markets Corp transactions in Alkermes Plc. stock. As of the latest transaction made, Cibc World Markets Corp holds 15,070 shares of ALKS stock, worth $540,108. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,070Holding current value
$540,108% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding ALKS
# of Institutions
375Shares Held
173MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$1.04 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$663 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$439 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$316 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$271 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.89B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...